Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders dahl salt-resistant rats hypertensive

Hypertension

Volumn 54, Issue 6, 2009, Pages 1284-1290

  Liclican, Elvira L ^a   Doumad, Anabel B ^a   Wang, Jianjin ^a   Li, Jing ^a   Falck, John R ^b   Stier, Charles T ^a   Carroll, Mairéad A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adenosine; EETs; Salt sensitive hypertension

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE 2A RECEPTOR; ADENOSINE RECEPTOR; EPOXYICOSATRIENOIC ACID; MESYLIC ACID DERIVATIVE; SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ALPHA 2 ADRENERGIC RECEPTOR; AMIDE; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; N METHYLSULFONYL 6 (2 PROPARGYLOXYPHENYL)HEXANAMIDE; N-METHYLSULFONYL-6-(2-PROPARGYLOXYPHENYL)HEXANAMIDE; OXIDOREDUCTASE; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DAHL SALT RESISTANT RAT; DIASTOLIC BLOOD PRESSURE; ENZYME INHIBITION; FATTY ACID BLOOD LEVEL; HYPERTENSION; IN VIVO STUDY; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RAT STRAIN; RECEPTOR BLOCKING; SALT INTAKE; SALT LOADING; SIGNAL TRANSDUCTION; SODIUM BALANCE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DAHL SALT SENSITIVE RAT; DRINKING; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RENOVASCULAR HYPERTENSION;

AMIDES; ANIMALS; BLOOD PRESSURE; DRINKING; EICOSANOIDS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION, RENAL; MALE; NATRIURESIS; OXIDOREDUCTASES; RATS; RATS, INBRED DAHL; RECEPTORS, ADRENERGIC, ALPHA-2; SODIUM CHLORIDE, DIETARY; TRIAZINES; TRIAZOLES;

EID: 73349088161     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.123570     Document Type: Article

References (35)

1. Blaustein MP, Zhang J, Chen L, Hamilton BP. How does salt retention raise blood pressure? Am J Physiol Regul Integr Comp Physiol. 2006; 290:R514-R523
2. Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972; 52:584-594
3. Aperia AC, Broberger CG, Soderlund S. Relationship between renal artery perfusion pressure and tubular sodium reabsorption. Am J Physiol. 1971;220:1205-1212
4. McGiff JC, Ferreri NR. Eicosanoids and the kidney. In: Alpern R, Hebert S, eds. The Kidney: Physiology and Pathophysiology. New York, NY: Elsevier Academic Press; 2008:359-384
5. Imig JD, Navar LG, Roman RJ, Reddy KK, Falck JR. Actions of epox-ygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol. 1996;7:2364-2370
6. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131-185
7. Huang H, Chang HH, Xu Y, Reddy DS, Du J, Zhou Y, Dong Z, Falck JR, Wang MH. Epoxyeicosatrienoic acid inhibition alters renal hemo-dynamics during pregnancy. Exp Biol Med (Maywood). 2006;231: 1744-1752
8. King LM, Gainer JV, David GL, Dai D, Goldstein JA, Brown NJ, Zeldin DC. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenet Genomics. 2005;15:7-13
9. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevila JH. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest. 1994;94:2414-2420
10. Zhao X, Pollock DM, Inscho EW, Zeldin DC, Imig JD. Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension. 2003;41: 709-714
11. Rapp JP, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension. 1985;7:340-349 (Pubitemid 15021172)
12. Roman RJ, Kaldunski M. Pressure natriuresis and cortical and papillary blood flow in inbred Dahl rats. Am J Physiol. 1991;261:R595-R602
13. Roman RJ, Kaldunski ML. Enhanced chloride reabsorption in the loop of Henle in Dahl salt-sensitive rats. Hypertension. 1991;17:1018-1024
14. Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 1991;251:799-802
15. Carroll MA, Sala A, Dunn CE, McGiff JC, Murphy RC. Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. J Biol Chem. 1991;266:12306-12312
16. Liclican EL, McGiff JC, Pedraza PL, Ferreri NR, Falck JR, Carroll MA. Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids. Am J Physiol Renal Physiol. 2005;289: F386-F392
17. Liclican EL, McGiff JC, Falck JR, Carroll MA. Failure to upregulate the adenosine 2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats. Am J Physiol Renal Physiol. 2008;295:F1696-F1704
18. Guimaraes S, Morato M, Sousa T, Albino-Teixeira A. Hypertension due to blockade of adenosine receptors. Pharmacol Toxicol. 2003;92: 160-162
19. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature. 1997;388:674-678
20. Stier CT Jr, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens. 1993;11(suppl):S37-S42
21. Poucher SM, Keddie JR, Brooks R, Shaw GR, McKillop D. Pharmaco-dynamics of ZM 241385, a potent A2a adenosine receptor antagonist, after enteric administration in rat, cat and dog. J Pharm Pharmacol. 1996;48:601-606
22. Carroll MA, Balazy M, Huang DD, Rybalova S, Falck JR, McGiff JC. Cytochrome P450-derived renal HETEs: storage and release. Kidney Int. 1997;51:1696-1702
23. Dhalla AK, Wong MY, Wang WQ, Biaggioni I, Belardinelli L. Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympatho-excitation in awake rats. J Pharmacol Exp Ther. 2006;316:695-702
24. Miller WL, Thomas RA, Berne RM, Rubio R. Adenosine production in the ischemic kidney. Circ Res. 1978;43:390-397
25. Okusa MD. A(2A) adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol. 2002;282:F10-F18
26. Lorenz JN, Weihprecht H, He XR, Skott O, Briggs JP, Schnermann J. Effects of adenosine and angiotensin on macula densa-stimulated renin secretion. Am J Physiol. 1993;265:F187-F194 (Pubitemid 23270335)
27. Yagil Y, Miyamoto M. The hypotensive effect of an oral adenosine analog with selectivity for the A2 receptor in the spontaneously hypertensive rat. Am J Hypertens. 1995;8:509-515
28. Kunes J, Zicha J, Jelínek J. The role of chloride in deoxycorticosterone hypertension: selective sodium loading by diet or drinking fluid. Physiol Res. 2004;53:149-154
29. Bayorh MA, Ogbolu EC, Williams E, Thierry-Palmer M, Sanford G, Emmett N, Harris-Hooker S, Socci RR, Chu TC, Chenault VM. Possible mechanisms of salt-induced hypertension in Dahl salt-sensitive rats. Physiol Behav. 1998;65:563-568
30. + in Dahl salt-sensitive vs.-resistant rats. Am J Physiol Heart Circ Physiol. 2001;281:H1881-H1889
31. Sun P, Liu W, Lin DH, Yue P, Kemp R, Satlin LM, Wang WH. Epoxyei-cosatrienoic acid activates BK channels in the cortical collecting duct. J Am Soc Nephrol. 2009;20:513-523
32. Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension. 2002;39:690-694
33. Li J, Carroll MA, Chander PN, Falck JR, Sangras B, Stier CT. Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension. Front Biosci. 2008;13:3480-3487
34. Loch D, Hoey A, Morisseau C, Hammock BO, Brown L. Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. Cell Biochem Biophys. 2007;47:87-98
35. Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension. 2005;46:975-981